EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 310 full-time employees. The firm's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. The company specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. The company also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Mr. Ryan Rhodes est le Chief Executive Officer de Edap Tms SA, il a rejoint l'entreprise depuis 2021.
Quelle est la performance du prix de l'action EDAP ?
Le prix actuel de EDAP est de $4.2, il a augmenté de 16.82% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Edap Tms SA ?
Edap Tms SA appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Edap Tms SA ?
La capitalisation boursière actuelle de Edap Tms SA est de $157.4M
Est-ce que Edap Tms SA est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 5 analystes ont établi des notations d'analystes pour Edap Tms SA, y compris 2 achat fort, 4 achat, 3 maintien, 0 vente et 2 vente forte